Health economics research aims to provide evidence on how to structure models of care to maximise the value for patients, improving health outcomes relative to the cost of providing care.
An Introduction to Health Economics and Economic Evaluation by Sabine Deij (PhD)
The type of methodology utilised will depend on the aim of the study, the intervention or model of care, phase of the study, and data availability. Cost-effectiveness and cost-utility analyses are well known economic evaluation methods and widely used . Other methodologies include looking at the return of investment of a particular intervention or discrete choice experiments (DCE) to find evidence of how clinicians, patients, carers, and the wider public value defined interventions/models of care.
I’ve rephrased because I felt that the original meaning was lost by replacing “most well-known” with widely used.
Current projects underway include:
- A health economic evaluation of a trial to understand whether it is safe to stop treatment using venetoclax in combination with azacitidine (VEN-AZA) for acute myeloid leukaemia (AML) patients who respond well to treatment (ADAPT-STOP trial),
- A cost-effectiveness analysis of a trial to test whether providing an education program via telehealth to abdominal and lung surgery patients before their surgery helps patients prepare for their surgery and reduces complications after surgery (STTARRS-trial),
- Costing of the pilot Preventing Cancer with MEDications (PCMed) Service, an intervention that provides advice to healthy women at increased risk of breast cancer on the use of breast cancer prevention medications.
To identify ways to incorporate Health Economics into your research, please contact:
Our Health Economics program is led by Professor Gang Chen.
Contact
Email: